Mycobacterium fortuitum Prosthetic Joint Infection After Total Hip Arthroplasty
William C. Fix, Neil P. Sheth, Michael N. Braffman
JBJS Case Connector · 2020-01
Abstract
CASE: A 57-year-old man presented with a Mycobacterium fortuitum prosthetic joint infection (PJI) after right total hip arthroplasty refractory to the initial revision surgery and cement spacer placement. The patient was subsequently treated with 2-stage total joint arthroplasty revision surgery using an antibiotic-laden spacer customized to include meropenem and delayed reimplantation to allow for prolonged, systemic antimicrobial treatment with multiple antimicrobials, including levofloxacin and linezolid. CONCLUSIONS: There is little evidence to guide practitioners in the diagnosis and treatment of PJI caused by rare, rapidly growing mycobacteria (RGM) such as M. fortuitum. This case demonstrates a successful strategy for the treatment of RGM PJI.
MeSH terms
- Mycobacterium fortuitum
- Medicine
- Meropenem
- Linezolid
- Levofloxacin
- Arthroplasty
- Surgery
- Antibiotics
- Joint arthroplasty